Lithium succinate
From Wikipedia, the free encyclopedia
![]() |
|
Lithium succinate
|
|
Systematic (IUPAC) name | |
lithium butanedioic acid | |
Identifiers | |
CAS number | ? |
ATC code | D11 |
PubChem | |
Chemical data | |
Formula | C4H5LiO4 |
Mol. mass | 124.02 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]
[edit] References
- ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel) 187 (2): 149–50. PMID 8358107.
- ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS 8 (8): 515–7. PMID 9259500.
|